Rimonabant, a cannabinoid receptor 1 antagonist, protects LDL receptor deficient mice from atherosclerosis.

被引：0
|
作者：
Dol-Gleizes, Frederique [1 ]
Visentin, Virgile [1 ]
Mares, Anne-Marie [1 ]
Schaeffer, Paul [1 ]
Bono, Francoise [1 ]
机构：
[1] Sanofi Aventis, Toulouse, France
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [41] AT1-receptor blockade is at least as effective as ACE inhibition in reducing atherosclerosis in LDL receptor-deficient mice
    Lee, TC
    Babaei, S
    Stewart, DJ
    CIRCULATION, 2000, 102 (18) : 318 - 318
  • [42] VasoCare™ treatment inhibits progression of atherosclerosis in LDL receptor (LDL-R) deficient mice
    Babaei, S
    Courtman, DW
    Stewart, DJ
    Donnelly, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 243A - 243A
  • [43] Hyperhomocysteinemia independently causes and promotes atherosclerosis in LDL receptor-deficient mice
    Hang-Yuan GUO
    Fu-Kang XU
    Hai-Tao LV
    Long-Bin LIU
    Zheng JI
    Xiao-Ya ZHAI
    Wei-Liang TANG
    Ju-Fang CHI
    Journal of Geriatric Cardiology, 2014, 11 (01) : 74 - 78
  • [44] Hyperhomocysteinemia independently causes and promotes atherosclerosis in LDL receptor-deficient mice
    Guo, Hang-Yuan
    Xu, Fu-Kang
    Lv, Hai-Tao
    Liu, Long-Bin
    Ji, Zheng
    Zhai, Xiao-Ya
    Tang, Wei-Liang
    Chi, Ju-Fang
    JOURNAL OF GERIATRIC CARDIOLOGY, 2014, 11 (01) : 74 - 78
  • [45] Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice
    Sukhova, GK
    Zhang, Y
    Pan, JH
    Wada, Y
    Yamamoto, T
    Naito, M
    Kodama, T
    Tsimikas, S
    Witztum, JL
    Lu, ML
    Sakara, Y
    Chin, MT
    Libby, P
    Shi, GP
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (06): : 897 - 906
  • [46] VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice
    VanderLaan, Paul A.
    Reardon, Catherine A.
    Thisted, Ronald A.
    Getz, Godfrey S.
    JOURNAL OF LIPID RESEARCH, 2009, 50 (03) : 376 - 385
  • [47] Vaccination against interleukin 12 attenuates atherosclerosis in LDL receptor deficient mice
    Hauer, A
    Uyttenhove, C
    de Vos, P
    Stroobant, V
    Renauld, J
    van Berkel, T
    van Snick, J
    Kuiper, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 41 - 42
  • [48] Sophora flavescens attenuates atherosclerosis and Hyperlipidemia in LDL receptor-deficient mice
    Han, Jong-Min
    An, Sojin
    Kim, Min-Jung
    Jin, Yue-Yan
    Baek, Seung-Wha
    Park, Ji-Seon
    Lee, Woo Song
    Park, Ki-Hoon
    Jeong, Tae-Sook
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E122 - E122
  • [49] Leukocyte Cathepsin C Deficiency Attenuates Atherosclerosis in LDL Receptor Deficient Mice
    Herias, Mayra V.
    Bai, Lili
    Medina, Indira
    Wijnands, Erwin
    Delsing, Dianne
    Pham, Christine
    Biessen, Erik A.
    Heeneman, Sylvia
    CIRCULATION, 2009, 120 (18) : S1166 - S1166
  • [50] Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing
    Horder, Jamie
    Browning, Michael
    Di Simplicio, Martina
    Cowen, Philip J.
    Harmer, Catherine J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (01) : 125 - 132
12345